ECRI

[WATCH NOW] The idea that diagnosis is a single event that happens at a single point of time by a single healthcare provider is a common misconception—one that doesn’t account for the complex, multifaceted system of patients, family members, providers, and technologies. In this episode, Victor Lane Rose, Executive Director, of Aging and Ambulatory Care at ECRI, discusses diagnosis and describes why patient, family, and caregiver participation is especially important in diagnosing Alzheimer’s and other dementias. Watch now on YouTube: https://hubs.la/Q02FPqPJ0 #dementiacare #seniorcare

Save money and time safely by using SurgiSmartIQ. SurgiSmartIQ helps you pinpoint areas where you are overspending, secure better prices, find alternative suppliers, negotiate stronger contracts with vendors, and identify discrepancies between contract prices and actual price paid. Better negotiate with stakeholders and clinicians and make informed decisions with confidence. Chat with our experts today: https://hubs.la/Q02DyqwZ0

❗Imagine detecting diseases before patients even show symptoms—it may now be possible with breakthrough MRI technology❗ A new MRI #technology is revolutionizing how we detect diseases at their earliest stages. This cutting-edge method promises to identify #diseases like cancer much earlier than current techniques, potentially saving countless lives through timely intervention. Northeastern University's new QUTE-CE MRI technology transforms traditional #MRI machines, offering non-invasive, high-resolution imaging that could revolutionize #diagnostics. What are your thoughts on the impact of such advancements in #healthcare? Could this be the game-changer we've been waiting for⁉️ Share your insights below and let’s discuss how we can leverage these innovations to improve patient outcomes. 💬 Source: https://hubs.la/Q02FHQjB0. #HealthcareInnovation #EarlyDetection #MedicalBreakthroughs #FutureOfHealthcare #ECRI #NortheasternUniversity

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that causes loss of muscle control and mobility, eventually leading to paralysis. The life expectancy for individuals with ALS is two to five years from diagnosis. ECRI’s Horizon Scanning Analysts are exploring a range of emerging interventions for this disease and need the input of the ALS community. Are you interested in sharing your insights? Fill out a brief form and a member of our team will be in touch: https://hubs.la/Q02DBPCy0 #amyotrophiclateralsclerosis #als #neurology #rarediseases #advocacy #innovation #patientcare #horizonscanning

In the latest edition of TechNation, ECRI shared insights on “Incident Management and Investigation: Mastering the Process.” The cover story features ECRI’s 7-point approach to manage and investigate healthcare incidents from beginning to end. The IMI Plan includes (1) awareness, (2) response, (3) fact gathering, (4) analysis, (5) conclusions (6) recommendations, and (7) legal considerations. “Hospital errors are the third-leading cause of death in the United States. After an incident occurs, it becomes imperative that a comprehensive investigation is completed to prevent recurrence and limit risk to the organization. However, missteps and gaps in the process, or a lack of investigation experience and resources, can leave organizations open to recurrence and costly claims,” says Barbara Malanga, director, preventative solutions and device safety operations-device safety at ECRI.” Read the cover story for ECRI expertise: https://hubs.la/Q02DWMx10

The number of orthopedic procedures in outpatient settings like ASCs is growing, exceeding inpatient procedures by 33 times, according to the American Joint Replacement Registry's 2023 annual report. With the rapid shift from acute care to ASCs, how can you be sure that you are maximizing savings? SurgiSmartIQ is designed to deliver data-driven cost savings to orthopedics by helping you: • Understand total joint costs • Assess contract compliance • Reduce spend safely Start realizing savings now: https://hubs.la/Q02DygSw0 #orthopedics #asc #ambulatorysurgerycenters

Patient safety and the uninterrupted supply of health-related products must be prioritized in policy discussions about trade restrictions and tariffs. ECRI submitted comments in response to the US Trade Representative (USTR)’s solicitation for input on proposed tariffs affecting $18 billion worth of goods manufactured in China, including medical products. ECRI urged the USTR to carefully consider potential adverse impacts of trade policy on patient safety as it relates to pharmaceuticals, medical devices, and healthcare supplies. It is critical to ensure the availability of medical products, such as syringes and their accessories, personal protective equipment, and other essential medical supplies. Read ECRI's full comments: https://hubs.la/Q02DMWBC0

Primary orthopedic hip and knee replacements are one of the fastest-growing procedures in US healthcare, driven by patient dynamics, surgeon preference, and involving a large variety of different manufacturers, components, and ancillary products. These elements drive complexity in supply chain management and reduce the ability to manage clinical use and variation. With the introduction of SurgiSmartIQ™, ECRI delivers a comprehensive solution that provides near time analytics and insights to help healthcare leaders realize cost savings, identify clinical variation and view procedure and contract compliance information down to the lowest level. Connect with us to start realizing savings now: https://hubs.la/Q02DyfM50 #orthopedics #asc #ambulatorysurgerycenters

PTSD can be difficult to treat, as trauma-focused psychotherapy can be distressing, leading patients to avoid or discontinue treatment. 3,4-Methylenedioxymethamphetamine (MDMA) is being evaluated as a means of enhancing PTSD psychotherapy by temporarily reducing the stress of processing traumatic memories. In clinical trials, it was reported that MDMA significantly and safely improved symptom relief achieved with psychotherapy, with effects lasting up to a year. Learn more about this investigational treatment in the latest Emerging Health Care Innovation Brief: https://hubs.la/Q02DBWBN0 #posttraumaticstressdisorder #ptsd #mentalhealth #patientcare #healthcare #innovation #horizonscanning #ecri

The approved drug therapies for posttraumatic stress disorder (PTSD) are not effective for many patients. BNC210 is a drug designed to reduce symptoms of PTSD through antidepressant and anxiety-reducing effects. While undergoing evaluation, BNC210 treatment significantly reduced symptoms of PTSD in as few as 4 weeks. A reduction in depression, insomnia, and intrusive thoughts were also reported. Learn more about this emerging intervention in the Emerging Health Care Innovation Brief: https://hubs.la/Q02DB-q30 #posttraumaticstressdisorder #ptsd #mentalhealth #patientcare #healthcare #innovation #horizonscanning #ecri